INDIGO Home University of Illinois at Urbana-Champaign logo uic building uic pavilion uic student center

Targeting Breast Cancer Stem Cells with the Curcumin Nanomedicine

Show simple item record

Bookmark or cite this item:

Files in this item

File Description Format
PDF Gulcur_Ece.pdf (1MB) (no description provided) PDF
Title: Targeting Breast Cancer Stem Cells with the Curcumin Nanomedicine
Author(s): Gulcur, Ece
Advisor(s): Onyuksel, Hayat
Department / Program: Biopharmaceutical Sciences
Graduate Major: Biopharmaceutical Sciences
Degree Granting Institution: University of Illinois at Chicago
Degree: MS, Master of Science
Genre: Masters
Subject(s): Curcumin Phospholipid micelles nanoparticles Breast cancer stem cells Targeted drug delivery Vasoactive intestinal peptide
Abstract: Purpose: Despite recent advances in breast cancer therapy, many patients still experience relapse. Evidence suggests that a sub-population of treatment-resistant “cancer stem cells” (CSCs) may be responsible for this tumor recurrence. Therefore, in this thesis project we aimed to develop a safe and efficacious nanomedicine that would target and eliminate breast CSCs. For this purpose, we evaluated the sterically stabilized nanomicellar formulation of curcumin (C-SSM), a promising dietary anti-cancer agent with a vast potential to target CSCs, for its in vitro inhibitory effect on breast CSCs and the potential of integrating an active targeting strategy directed to CSCs. Methods: MCF-7 cells were chosen as the model system for this project. C-SSM composed of distearoyl phosphatidylethanolamine-polyethylene glycol 2000 (DSPE-PEG 2000) were prepared using the film rehydration method and characterized for particle size using dynamic light scattering. The in vitro inhibitory effect of the C-SSM nanomedicine on breast CSCs was evaluated and compared to that of free curcumin using a tumorsphere formation assay and flow cytometric analyses of the cellular drug uptake as well as the percentage of CD44+/CD24-/low CSC population. The expression of vasoactive intestinal peptide (VIP) receptors on breast CSCs was investigated using a fluorescence-based ligand binding assay, followed by confocal microscopy. VIP-surface grafted C-SSM (C-SSM-VIP) were prepared by conjugating VIP to the activated DSPE-PEG (MW:3400) and incorporating these constructs into C-SSM. The effect of VIP-surface grafting on the anti-CSC activity of C-SSM was evaluated using a tumorsphere formation assay. Results: Pre-treatment of MCF7 cells with 10 or 20 μM C-SSM (~15 nm in diameter) inhibited tumorsphere formation by 34% (P < 0.05) and 64% (P < 0.001), respectively. 20 µM C-SSM increased tumorsphere inhibition by > 2-fold compared to free curcumin. C-SSM was also found to reduce sphere size (~50%; P < 0.05) and to inhibit secondary tumorsphere formation (22%; P < 0.05). The flow cytometric analyses demonstrated that C-SSM (10 µM and 20 µM) markedly increased the intracellular uptake of curcumin compared to free drug (1.8-fold – 6.4-fold) in both CD44+/CD24-/low CSC and normal cancer cell (NCC) populations. In addition, 20 µM C-SSM reduced the percentage of the CD44+/CD24-/low CSCs by 56% (P < 0.05), while no significant change was observed with free curcumin. The VIP receptor expression study showed a ~3-fold overexpression (P < 0.05) in the CD44+/CD24-/low CSC population compared to the NCCs in the MCF-7 cell line. The C-SSM-VIP nanomedicine (~17 nm), at a lower concentration (5 µM), was found to enhance inhibition of tumorsphere formation by approximately 20% (P < 0.05) compared to both C-SSM and free curcumin. Conclusion: C-SSM significantly enhanced the efficacy of curcumin against breast CSCs in vitro. Moreover, active targeting of the VIP receptors, found to be overexpressed on breast CSCs, with C-SSM-VIP further improved the anti-CSC activity of C-SSM. Therefore, the nanomicellar formulations of curcumin may provide a novel strategy for a relapse-free cure of breast cancer by targeting and eliminating CSCs.
Issue Date: 2012-12-10
Genre: thesis
Rights Information: Copyright 2012 Ece Gulcur
Date Available in INDIGO: 2012-12-10
Date Deposited: 2012-05

This item appears in the following Collection(s)

Show simple item record


Country Code Views
United States of America 246
China 50
India 23
United Kingdom 15
Iran 12


My Account


Access Key